Expanding Phase III Study of Tyroserleutide for Injection
Clinical trial NCT03516448 · UNKNOWN
Trial details
- NCT number
- NCT03516448
- Sponsor
- Shenzhen Kangzhe Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-24
- Primary completion
- 2016-06-13
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.